BTF3 Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P20290 |
---|---|
Clone Names | 80102145 |
Gene ID | 689 |
---|---|
Other Names | Transcription factor BTF3, Nascent polypeptide-associated complex subunit beta, NAC-beta, RNA polymerase B transcription factor 3, BTF3, NACB |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | BTF3 |
---|---|
Synonyms | NACB |
Function | When associated with NACA, prevents inappropriate targeting of non-secretory polypeptides to the endoplasmic reticulum (ER). Binds to nascent polypeptide chains as they emerge from the ribosome and blocks their interaction with the signal recognition particle (SRP), which normally targets nascent secretory peptides to the ER. BTF3 is also a general transcription factor that can form a stable complex with RNA polymerase II. Required for the initiation of transcription. |
Cellular Location | Cytoplasm. Nucleus. Note=The heterodimer with NACA is cytoplasmic |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes the basic transcription factor 3. Thisprotein forms a stable complex with RNA polymerase IIB and isrequired for transcriptional initiation. Alternative splicingresults in multiple transcript variants encoding differentisoforms. This gene has multiple pseudogenes.
References
Green, C.D., et al. Mol. Cancer Res. 5(11):1191-1200(2007)Matsuoka, S., et al. Science 316(5828):1160-1166(2007)Kusumawidjaja, G., et al. Cancer Biol. Ther. 6(3):367-376(2007)Freire, M.A. Gene 345(2):271-277(2005)Harrington, J.J., et al. Nat. Biotechnol. 19(5):440-445(2001)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.